Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research. This week, we have another exclusive interview from the ADA 2018 in Orlando.
Jon S. Odorico, MD, FACS is Director of the Pancreas and Islet Cell Transplantation Programs and Professor in the Department of Surgery, Division of Organ Transplantation at the University of Wisconsin-Madison School of Medicine and Public Health. In addition, Odorico is a research associate at the WiCell Institute in Wisconsin. Dr. Odorico received his B.S. in Chemistry from Duke University, an M.D. from New York University, and completed his residency in general surgery as well as a post-doctoral research fellowship, studying islet transplantation and thymic tolerance, at the University of Pennsylvania in Philadelphia. Dr. Odorico is certified by the American Board of Surgery and specializes in pancreatic, islet cell, and multi-organ transplants.
Dr. Odorico has an active research laboratory that focuses on beta cell differentiation from stem cells for studying pancreas development and for developing novel stem cell-based strategies for treating diabetes. He is Scientific Co-founder and Chair of the Scientific Advisory Board of Regenerative Medical Solutions, Inc. (RMS), a biotechnology company developing cellular and media products for researchers in academia and the pharmaceutical industry for drug discovery and testing applications as well as therapy for patients with all forms of diabetes.
Dr. Odorico’s research has been supported by the National Institutes of Health, Juvenile Diabetes Research Foundation, American Diabetes Association, ASTS, and WiCell Institute. He serves as Associate Editor of the American Journal of Transplantation, Immediate Past President of the International Pancreas and Islet Transplant Association as well as Chair of the United Network of Organ Sharing Pancreas Committee.
Featured videos include:
Pt.2: Viacyte Stem Cell Trial
or to see this interview in full, click here: Complete Interview.